Please Wait
Applying Filters...
menu
    • menu
    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

    Virtual Booth

    Contact Supplier

    dmfs-not-supported-m-2025-05-19

    Virtual Booth

    An Enquiry

    Chirogate is a professional Prostaglandin manufacturer.

    Virtual Booth

    Contact Supplier

    Temad- We think of world-class quality.

    Virtual Booth

    Contact Supplier

    jdmfs-not-supported-m-2025-04-28

    Virtual Booth

    An Enquiry

    Menu

    Lacutamab

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Innate Pharma Reports Durable Lacutamab Results
    Innate Pharma Reports Durable Lacutamab Results

    23 May 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250522071107/en/Innate-Pharma-Highlights-Durable-Responses-to-Lacutamab-in-Sezary-Syndrome-and-Mycosis-Fungoides

    BUSINESSWIRE
    23 May 2025
    Share Share
    Innate Pharma’s Lacutamab Gets FDA Breakthrough Therapy For SS
    Innate Pharma’s Lacutamab Gets FDA Breakthrough Therapy For SS

    17 Feb 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250216384344/en

    BUSINESSWIRE
    17 Feb 2025
    Share Share
    Innate Pharma: Positive Phase 2 Lacutamab Data In Mycosis Fungoides
    Innate Pharma: Positive Phase 2 Lacutamab Data In Mycosis Fungoides

    04 Jun 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240603023665/en

    BUSINESSWIRE
    04 Jun 2024
    Share Share
    Innate Pharma Announces U.S. FDA Lifts Partial Hold on Lacutamab Program
    Innate Pharma Announces U.S. FDA Lifts Partial Hold on Lacutamab Program

    04 Jan 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240103221044/en

    BUSINESSWIRE
    04 Jan 2024
    Share Share
    Innate Presents Positive Results From TELLOMAK Phase 2 Study With Lacutamab
    Innate Presents Positive Results From TELLOMAK Phase 2 Study With Lacutamab

    10 Dec 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20231209939521/en

    BUSINESSWIRE
    10 Dec 2023
    Share Share
    Innate Pharma Announces Presentation of Interim Results of Ph 2 TELLOMAK Study
    Innate Pharma Announces Presentation of Interim Results of Ph 2 TELLOMAK Study

    22 Sep 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230921031989/en

    BUSINESSWIRE
    22 Sep 2023
    Share Share